Large-scale testing (Phase 3)Study completedNCT03469349
What this trial is testing
Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB
Who this might be right for
Peripheral Arterial Diseases
Takeda 366